CMBA
DPLO

C.M. Bidwell & Associates’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History

C.M. Bidwell & Associates’s Portfolio DPLO Stock Details DPLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,510
Closed -$211K – 460
2017
Q4 		$211K Buy
10,510
+760
+8% +$14.9K 0.18% 150
2017
Q3 		$202K Buy
+9,750
New +$165K 0.31% 121

Other funds holding DPLO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

C.M. Bidwell & Associates's DPLO Position: Q1 2018 in Review

C.M. Bidwell & Associates sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2018, closing a stake of 10,510 shares — an estimated $211K sold.

C.M. Bidwell & Associates first reported a position in DPLO in Q3 2017 and held it in 2 quarters. The position peaked at $211K in Q4 2017. 201 funds tracked by Wall St. Rank hold DPLO as of Q1 2018.

  • C.M. Bidwell & Associates reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2018 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 10,510 DIPLOMAT PHARMACY, INC. shares in Q1 2018, an estimated $211K.
  • C.M. Bidwell & Associates first reported a position in DIPLOMAT PHARMACY, INC. in Q3 2017 and held it in 2 quarters.
  • C.M. Bidwell & Associates's DIPLOMAT PHARMACY, INC. position peaked at $211K in Q4 2017.
  • 201 funds tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2018.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2018, filed 11 May 2018.